HROW
Harrow Inc
NASDAQ · Pharmaceuticals
$47.32
+1.26 (+2.74%)
Open$46.54
Previous Close$46.06
Day High$48.01
Day Low$45.66
52W High$54.85
52W Low$20.85
Volume—
Avg Volume593.2K
Market Cap1.75B
P/E Ratio—
EPS$-0.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-47.9% upside
Current
$47.32
$47.32
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 207.38M | 147.95M | 741.62M |
| Net Income | -18,159,463 | -11,659,782 | 118.74M |
| Profit Margin | -8.8% | -8.3% | 16.0% |
| EBITDA | 10.90M | 7.39M | 202.60M |
| Free Cash Flow | — | — | 69.51M |
| Rev Growth | +40.2% | +40.2% | +13.7% |
| Debt/Equity | 3.15 | 3.15 | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |